Your browser doesn't support javascript.
loading
Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials.
Sydes, Matthew R; Murray, Macey L; Ahmed, Saiam; Apostolidou, Sophia; Bliss, Judith M; Bloomfield, Claire; Cannings-John, Rebecca; Carpenter, James; Clayton, Tim; Clout, Madeleine; Cosgriff, Rebecca; Farrin, Amanda J; Gentry-Maharaj, Aleksandra; Gilbert, Duncan C; Harper, Charlie; James, Nicholas D; Langley, Ruth E; Lessels, Sarah; Lugg-Widger, Fiona; Mackenzie, Isla S; Mafham, Marion; Menon, Usha; Mintz, Harriet; Pinches, Heather; Robling, Michael; Wright-Hughes, Alexandra; Yorke-Edwards, Victoria; Love, Sharon B.
Afiliação
  • Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK; Health Data Research UK (HDR UK), London, UK; BHF Data Science Centre, Health Data Research UK (HDR UK), London, UK. Electronic address: m.sydes@ucl.ac.uk.
  • Murray ML; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK; Health Data Research UK (HDR UK), London, UK. Electronic address: macey.murray@ucl.ac.uk.
  • Ahmed S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK; UCL Comprehensive Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: saiam.ahmed@ucl.ac.uk.
  • Apostolidou S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: s.apostolidou@ucl.ac.uk.
  • Bliss JM; Clinical Trials and Statistics Unit, Division of Clinical Studies, The Institute of Cancer Research, London, UK. Electronic address: judith.bliss@icr.ac.uk.
  • Bloomfield C; Insitro Inc, San Francisco, CA, USA; NHS Transformation Directorate, NHS England & NHS Improvement, London, UK. Electronic address: cbloomfield@insitro.com.
  • Cannings-John R; Centre for Trials Research, Cardiff University, Cardiff, UK. Electronic address: canningsrl@cardiff.ac.uk.
  • Carpenter J; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK; London School of Hygiene and Tropical Medicine, London, UK. Electronic address: j.carpenter@ucl.ac.uk.
  • Clayton T; Department of Medical Statistics and Clinical Trials Unit, London School of Hygiene and Tropical Medicine (LSHTM), London, UK. Electronic address: Tim.Clayton@lshtm.ac.uk.
  • Clout M; Bristol Trials Centre, University of Bristol, Bristol, UK. Electronic address: madeleine.clout@bristol.ac.uk.
  • Cosgriff R; NHS Transformation Directorate, NHS England & NHS Improvement, London, UK. Electronic address: r.cosgriff@nhs.net.
  • Farrin AJ; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK. Electronic address: A.J.Farrin@leeds.ac.uk.
  • Gentry-Maharaj A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK; Department of Women's Cancer, UCL Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK. Electronic address: a.gentry-maharaj@ucl.ac.uk.
  • Gilbert DC; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: duncan.gilbert@ucl.ac.uk.
  • Harper C; Nuffield Department of Population Health, University of Oxford, Oxford, UK. Electronic address: charlie.harper@ndph.ox.ac.uk.
  • James ND; The Institute of Cancer Research, London, UK. Electronic address: nick.james@icr.ac.uk.
  • Langley RE; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: ruth.langley@ucl.ac.uk.
  • Lessels S; BHF Data Science Centre, Health Data Research UK (HDR UK), London, UK. Electronic address: Sarah.Lessels@hdruk.ac.uk.
  • Lugg-Widger F; Centre for Trials Research, Cardiff University, Cardiff, UK. Electronic address: LuggFV@cardiff.ac.uk.
  • Mackenzie IS; MEMO Research, Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK. Electronic address: i.s.mackenzie@dundee.ac.uk.
  • Mafham M; Health Data Research UK (HDR UK), London, UK; Nuffield Department of Population Health, University of Oxford, Oxford, UK; Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), NDPH, University of Oxford, Oxford, UK. Electronic address: marion.mafham@ndph.ox.ac.uk.
  • Menon U; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: u.menon@ucl.ac.uk.
  • Mintz H; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: HXM074@student.bham.ac.uk.
  • Pinches H; NHS DigiTrials, NHS England, Leeds, UK. Electronic address: h.pinches@nhs.net.
  • Robling M; Centre for Trials Research, Cardiff University, Cardiff, UK. Electronic address: Roblingmr@cardiff.ac.uk.
  • Wright-Hughes A; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK. Electronic address: A.Wright-Hughes@leeds.ac.uk.
  • Yorke-Edwards V; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK; Centre for Advanced Research Computing, University College London, London, UK. Electronic address: v.yorke-edwards@ucl.ac.uk.
  • Love SB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: s.love@ucl.ac.uk.
Contemp Clin Trials ; 141: 107514, 2024 06.
Article em En | MEDLINE | ID: mdl-38537901
ABSTRACT

BACKGROUND:

Better use of healthcare systems data, collected as part of interactions between patients and the healthcare system, could transform planning and conduct of randomised controlled trials. Multiple challenges to widespread use include whether healthcare systems data captures sufficiently well the data traditionally captured on case report forms. "Data Utility Comparison Studies" (DUCkS) assess the utility of healthcare systems data for RCTs by comparison to data collected by the trial. Despite their importance, there are few published UK examples of DUCkS. METHODS-AND-

RESULTS:

Building from ongoing and selected recent examples of UK-led DUCkS in the literature, we set out experience-based considerations for the conduct of future DUCkS. Developed through informal iterative discussions in many forums, considerations are offered for planning, protocol development, data, analysis and reporting, with comparisons at "patient-level" or "trial-level", depending on the item of interest and trial status.

DISCUSSION:

DUCkS could be a valuable tool in assessing where healthcare systems data can be used for trials and in which trial teams can play a leading role. There is a pressing need for trials to be more efficient in their delivery and research waste must be reduced. Trials have been making inconsistent use of healthcare systems data, not least because of an absence of evidence of utility. DUCkS can also help to identify challenges in using healthcare systems data, such as linkage (access and timing) and data quality. We encourage trial teams to incorporate and report DUCkS in trials and funders and data providers to support them.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos Controlados Aleatórios como Assunto Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos Controlados Aleatórios como Assunto Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article